Lomitapide (Juxtapid® in US and Lojuxta® in Europe) is the first developed inhibitor of the microsomal triglyceride transfer protein (MTP) approved as a novel drug for the management of homozygous familial hypercholesterolemia (HoFH). It acts by binding directly and selectively to MTP thus decreasing the assembly and secretion of the apo-B containing lipoproteins both in the liver and in the intestine.

Giammanco, A., Cefalù, A.B., Noto, D., Averna, M. (2020). Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide. CURRENT MEDICINAL CHEMISTRY, 27(23), 3773-3783 [10.2174/0929867326666190121120735].

Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide

Giammanco, Antonina;Cefalù, Angelo B;Noto, Davide;Averna, Maurizio
2020-01-01

Abstract

Lomitapide (Juxtapid® in US and Lojuxta® in Europe) is the first developed inhibitor of the microsomal triglyceride transfer protein (MTP) approved as a novel drug for the management of homozygous familial hypercholesterolemia (HoFH). It acts by binding directly and selectively to MTP thus decreasing the assembly and secretion of the apo-B containing lipoproteins both in the liver and in the intestine.
Giammanco, A., Cefalù, A.B., Noto, D., Averna, M. (2020). Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide. CURRENT MEDICINAL CHEMISTRY, 27(23), 3773-3783 [10.2174/0929867326666190121120735].
File in questo prodotto:
File Dimensione Formato  
Therapeutic Options for Homozygous Familial Hypercholesterolemia_correted proof.pdf

Solo gestori archvio

Tipologia: Pre-print
Dimensione 447.74 kB
Formato Adobe PDF
447.74 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/387950
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact